
PANS Pharmacy Challenge
1. A patient taking clopidogrel experiences reduced antiplatelet activity after starting another medication. Which enzyme-related interaction most directly explains this effect?
A. Metformin inhibition of CYP2C19
B. Amoxicillin inhibition of CYP2C19
C. Omeprazole inhibition of CYP2C19
D. Rifampicin inhibition of CYP2C19
2. Which pharmacokinetic parameter is most directly used to estimate the total systemic exposure to a drug after a single dose?
A. Elimination half-life (t½)
B. Area under the plasma concentration-time curve (AUC)
C. Maximum plasma concentration (Cmax)
D. Time to maximum concentration (Tmax)
3. A 10-year-old child with suspected PANS presents with severe OCD symptoms and anxiety. The multidisciplinary team considers initiating fluoxetine. Which pharmacological consideration is MOST important when initiating treatment in this patient?
A. Start at a low dose and titrate cautiously while monitoring for behavioural activation, increased agitation and suicidal ideation
B. Fluoxetine should be started at the standard adult dose because its long half-life prevents toxicity in children
C. Fluoxetine should be combined routinely with haloperidol to prevent serotonin-related adverse effects
D. Fluoxetine produces immediate anti-obsessional effects through direct dopamine receptor blockade
4. A child with PANS has received repeated courses of azithromycin for presumed infectious triggers. The pharmacist reviews the prescription and notes a history of congenital long-QT syndrome. Which is the MOST appropriate pharmaceutical intervention?
A. Increase the azithromycin dose to shorten treatment duration and minimise cardiac exposure
B. Continue azithromycin because macrolides have no clinically significant cardiac effects in children
C. Recommend switching automatically to clarithromycin because it does not affect cardiac repolarisation
D. Flag the QT-prolongation risk, recommend avoiding azithromycin where possible and discuss an appropriate alternative with the prescriber





C
B
A
D
C
B
A
D
C
B
A
D
1. C
2. B
3. A
4. D
C
B
A
D
C
B
A
D